Venture Devils startup, bioSyntagma, wins NSF grant
ASU Venture Devils team, bioSyntagma LLC, was awarded a $213,904 National Science Foundation (NSF) Small Business Innovation (SBIR) grant to conduct research and development. bioSyntagma is a faculty-based Venture Devil startup that has developed the capability to extract single and multi-cells from a variety of sample types using a simple, and cost effective, microfluidic tissue chip, the LightStream FloCell.
David Richardson, pictured above (far right), with his team at ASU SkySong
In discussions about the NSF grant Richardson said, “We are grateful for the recognition and support of the National Science Foundation of our efforts and potential of our technology. This funding will allow us to further develop our technology, the application of which has such profound implications in understanding the underlying causes across diverse disease states that have an enormous personal impact, and which are a heavy burden on our healthcare system and society.”
For more information regarding bioSyntagma and their NSF grant, please review the press release here.
2023 Holiday Gift Guide: Shop Brands That Elevate Entrepreneurs
November 16, 2023
Our annual holiday gift guide is back! This year, we present a curated selection of twenty-two remarkable small businesses that are part of our vibrant community programs and Venture Devils.
Art Meets Business: Four Creative Minds Crafting Success
October 24, 2023
As we continue to build resources and support for creative entrepreneurs at Edson E+I, we strive to show, rather than tell, our community that entrepreneurship is for everyone, and that
Aspiring entrepreneurs face a daunting challenge: transforming their startup dreams into market-viable solutions. How do you make sure people want to buy what you are selling? Identifying–and understanding–your product-market fit
